Zymeworks Inc. ZYME 深 沪
已收盘 07-02 16:00:00 美东时间
26.31
+0.590
+2.29%
华盛通- 最 高26.32
- 今 开25.78
- 成交量 56.38万股
- 最 低 25.40
- 昨 收 25.72
- 总市值 19.36亿
- 52周最高 29.75
- 市盈率 静 --
- 换手率 0.77%
- 52周最低 11.51
- 委 比 33.77%
- 总股本 7357.39万
- 历史最高 59.03
- 量 比 0.69
- 振 幅 3.58%
- 历史最低 4.11
- 每 手 1
- 风险率 4.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Bernstein上调闪迪目标价从1700美元升至3000美元；大摩上调谷歌-A目标价从375美元升至415美元
今日重点评级关注：Citizens：维持DBV Technologies"跑赢大市"评级，目标价从47美元升至55美元；康托·菲茨杰拉德：维持BioCryst制药"超配"评级，目标价从27美元升至29美元
07-01 10:40
杰富瑞维持对Zymeworks（ZYME）的买入评级
杰富瑞维持对Zymeworks的“买入”评级，设定43.00美元目标价。当前分析师对Zymeworks的共识评级为“强力买入”，平均目标价38.86美元。 Z...
07-01 00:00
富国银行维持Zymeworks增持评级 将目标价上调至37美元
富国银行分析师Eva Fortey Beldho维持Zymeworks的“增持”评级，将其目标价从34美元上调至37美元。 译文内容由第三方软件翻译。 声明：市...
06-30 22:40
分析师解读医疗健康企业：Zymeworks（ZYME）、Celldex（CLDX）与ACADIA Pharmaceuticals（ACAD）
医疗保健领域近期释放乐观信号，三名分析师分别对Zymeworks（ZYME）、Celldex（CLDX）、ACADIA制药（ACAD）发布看涨评级。 Zym...
06-30 19:12
Theravance downgraded at Jones on Zymeworks acquisition
Jones Trading has downgraded Theravance Biopharma (TBPH) to hold from buy following the announcement earlier Monday that Zymeworks (ZYME) is acquiring the company in a $929M deal. Analyst Debanjana Ch...
06-30 02:36
Zymeworks Targets Long-Term Cash Generation Through Theravance Acquisition
Zymeworks Inc. (NASDAQ:ZYME) said Monday it has agreed to acquire Theravance Biopharma Inc. (NASDAQ:TBPH) in an all-cash transaction valued at about $929 million. The deal, which aims to bolster Zymeworks’ commercial portfolio, will pay $17 per share for Theravance Biopharma shares. The companies ex...
06-29 21:20
Zymeworks to Acquire Theravance in Strategic Merger
Zymeworks ( ($ZYME) ) has issued an update. On June 28, 2026, Zymeworks Inc. ag...
06-29 19:49
Theravance Biopharma to be Acquired by Zymeworks
The latest update is out from Theravance Biopharma ( ($TBPH) ). Theravance Biop...
06-29 18:59
Zymeworks将收购Theravance Biopharma, Inc.
核心事件：Zymeworks将收购Theravance Biopharma有限公司。 译文内容由第三方软件翻译。 声明：市场有风险，投资需谨慎。本文由AI大模型...
06-29 18:03
Zymeworks Said To Near $929M Deal For Theravance At $17 Per Share, Bloomberg News Reports
https://www.bloomberg.com/news/articles/2026-06-29/zymeworks-said-to-near-929-million-deal-for-theravance
06-29 17:26
